鲍曼不动杆菌感染的临床分布及耐药性分析

目的：了解鲍曼不动杆菌的临床分布及其对常用抗生素的耐药情况,为临床抗感染治疗提供依据.方法：回顾分析2007年1月-2009年12月自临床标本中分离的鲍曼不动杆菌391株,应用VITEK32的GNI卡对临床标本中分离出的细菌进行鉴定,药敏纸片进行药物敏感试验.结果：3年共分离出鲍曼不动杆菌391株,在临床标本中,痰液分布率最高,占68.3%,感染分布以ICU为主,占33.8%,药敏结果显示,其对β-内酰胺类、喹诺酮类和氨基糖苷类有较高的耐药率,对碳青酶烯类,含酶抑制剂敏感性较高.结论：鲍曼不动杆菌耐药率呈逐年上升趋势,临床抗感染治疗应依据药物敏感试验结果合理选用抗生素.

Bormann not know the purpose of the clinical bacilli distribution and its use of antibiotics on drug case, the clinical treatment based on resistance to infection, the method provides ： review and analysis in january, 2007 -- 2009 from clinical specimens in december of bormann not bacilli 391 is applied, vitek32 of clinical specimens gni card to the identification of bacteria, medicine, drug trials, a sensitive paper. Results ; three years have been isolated bormann not bacilli 391 is, in clinical specimens of the highest in the distribution of 68.3%, infection, accounting for distribution in the icu 33.8%, medicine and as a result, it＇s very kind to penicillin, sand and the celebration of the main categories have a high rate of drug, carbon is a type of fuel are tied with a kind of inhibitor sensitivity high. Conclusion ： bormann not bacilli drug rate is rising year by year, the clinical treatment should be based on resistance to infection of drug sensitive test results reasonable choice of antibiotics.